Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Prurigo Nodularis Clinical Trials

A listing of Prurigo Nodularis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (12) clinical trials

Intense Itching with Prurigo Nodularis? Right now, doctors at Medical Center for Clinical Research in San Diego are conducting a new research study for chronic itch with prurigo nodularis (PN). The study is for an investigational medication that may help reduce uncomfortable itching associated with PN.

Phase N/A

This is a double-blind, randomized, placebo-controlled study to assess the efficacy, safety, and tolerability of serlopitant for the treatment of pruritus (itching) in adults with prurigo nodularis (abbreviated as PN, a skin condition with multiple very itchy, solid skin bumps that develop due to scratching).  All enrolled subjects will receive ...

Phase

Chronic itch associated with Prurigo Nodularis

Phase

The PRISM Study is for adults 18 years of age and older who have been diagnosed with Prurigo Nodularis. The purpose of this study, is to test the safety and effectiveness of an investigational study drug for Pruritus (“Itch”) Relief.

Phase N/A

This is a research study of an investigational drug called serlopitant, which is being tested for the treatment of pruritus in people with prurigo nodularis (abbreviated as PN, a skin condition with multiple very itchy, solid skin bumps that develop due to scratching).  Pruritus, also called itch, is defined as ...

Phase N/A

A research study is evaluating an investigational medication for Prurigo Nodularis (PN), a condition characterized by intensely itchy nodules on the skin. Those with PN often find that scratching does not relieve the itch.

Phase N/A

Prurigo Nodularis study evaluating a potential new oral medication

Phase

Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)

Study of the long term safety of serlopitant for the treatment of pruritus in adults.

Phase

Study of the Efficacy Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis

Study of the efficacy, safety, and tolerability of serlopitant for the treatment of pruritus in adults with prurigo nodularis

Phase

Apremilast as Anti-pruritic Treatment in Patients With Prurigo Nodularis

Prurigo nodularis(PN) is a chronic skin disease, characterized by severe pruritus, multiple hyperkeratotic nodules and papules often located on the extensor part of the upper and lower extremities with a symmetrical distribution. The disease often appears between 20-60 years of age affecting men and women equally. The pathogenesis of PN ...

Phase